Amy Clem
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer
- Mitochondrial Function and Pathology
- Epigenetics and DNA Methylation
Papers in
-
- Cancer, Hypoxia, and Metabolism 16
-
- Metabolism, Diabetes, and Cancer 8
- PI3K/AKT/mTOR signaling in cancer 3
- Protein Kinase Regulation and GTPase Signaling 2
- Co-authors
- Jason Chesney (22 shared papers)Sucheta Telang (15 shared papers)Brian F. Clem (14 shared papers)Abdullah Yalçın (9 shared papers)John W. Eaton (5 shared papers)Andrew N. Lane (4 shared papers)Yoannis Imbert-Fernandez (8 shared papers)John O. Trent (4 shared papers)
- Journals
- Oncogene (3 papers)Cancer Research (2 papers)Journal of Translational Medicine (2 papers)Journal of Biological Chemistry (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesTürkiyeArgentina
In The Last Decade
Amy Clem
23 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 1.0k
- Molecular Biology 1.1k
- Oncology 351
- Immunology 269
- Cell Biology 103
Countries citing papers authored by Amy Clem
This map shows the geographic impact of Amy Clem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Clem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Clem more than expected).
Fields of papers citing papers by Amy Clem
This network shows the impact of papers produced by Amy Clem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Clem. The network helps show where Amy Clem may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Clem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 348 | |
| 2 | 2013 | 223 | |
| 3 | 2009 | 194 | |
| 4 | 2014 | 161 | |
| 5 | 2006 | 138 | |
| 6 | 2008 | 118 | |
| 7 | 2016 | 84 | |
| 8 | 2009 | 82 | |
| 9 | 2014 | 82 | |
| 10 | 2014 | 77 | |
| 11 | 2012 | 77 | |
| 12 | 2011 | 62 | |
| 13 | 2007 | 52 | |
| 14 | 2005 | 51 | |
| 15 | 2011 | 50 | |
| 16 | 2020 | 38 | |
| 17 | 2003 | 30 | |
| 18 | 2007 | 28 | |
| 19 | 2016 | 2 | |
| 20 | 2006 | 2 |
About Amy Clem
Amy Clem is a scholar working on Cancer Research, Molecular Biology, Oncology, Cell Biology and Surgery, having authored 23 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (16 papers), Cancer-related Molecular Pathways (9 papers), Metabolism, Diabetes, and Cancer (8 papers), Microtubule and mitosis dynamics (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), CAR-T cell therapy research (2 papers) and Vitamin C and Antioxidants Research (1 paper). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.1k citations), Oncology (351 citations), Immunology (269 citations) and Cell Biology (103 citations). Amy Clem has collaborated with scholars based in United States, Türkiye and Argentina. Frequent co-authors include Jason Chesney, Sucheta Telang, Brian F. Clem, Abdullah Yalçın, John W. Eaton, Andrew N. Lane, Yoannis Imbert-Fernandez, John O. Trent, Julie O’Neal and Alden C. Klarer. Their work appears in journals such as Oncogene, Cancer Research, Journal of Translational Medicine, Journal of Biological Chemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.